Xstrahl, a company specializing in radiation delivery devices for cancer treatment, has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Radiant Aura treatment system. Radiant Aura is a small office-based radiation therapy device designed for dermatology practices. It offers dermatologists multiple treatment options for patients with non-melanoma skin cancer (NMSC) when surgery is not possible or preferred. The device has been developed in collaboration with clinical users and features an extended range of motion, easy maneuverability, and improved patient safety. Xstrahl has also introduced new applicators for more precise radiation delivery. The company's CEO, Adrian Treverton, stated that Radiant Aura is the next generation of their radiation therapy systems and includes upgrades based on user experience and recommendations.
Wed, 19 Jul 2023 08:44:21 GMT | Medical Device Network